{"title": "vaccine efficacy: Latest News & Videos, Photos about vaccine efficacy | The Economic Times - Page 1", "author": null, "url": "https://economictimes.indiatimes.com/topic/vaccine-efficacy", "hostname": "indiatimes.com", "description": "vaccine efficacy Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. vaccine efficacy Blogs, Comments and Archive News on Economictimes.com", "sitename": "The Economic Times", "date": "2021-06-29", "cleaned_text": "EFFICACY Eris: Symptoms, Vaccines and all about the new dominant Covid variant which is leading to a fresh wave in the U.S and U.K The Eris variant, or EG.5, a dominant Covid subvariant, has surged to prominence as the most prevalent subvariant in the United States and the United Kingdom raising concerns. Is US getting new Covid vaccine? Here's President Joe Biden's bold plan for mandatory immunization US President Biden has introduced a proactive strategy aimed at securing additional funding from Congress to support the development of a groundbreaking COVID-19 vaccine. Covid 19 vaccines' updated versions to be available in US market in September, say CDC, FDA officials. Check age limit, where to get Covid-19 vaccines' updated versions will be available in the US by mid-September and will be distributed through the commercial market, CDC, FDA officials revealed. Indian Immunologicals targets dengue vaccine launch by January 2026 Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first such vaccine heats up. Dengue, a mosquito-borne disease, has over the last few years become a major public health concern in India, with 31,464 dengue cases and 36 related deaths reported between January and July 31, 2023. What is 'Disease X'? UK Scientists prepare vaccines against potential new pandemic A group comprising over 200 scientists is gearing up at a heavily fortified facility in the United Kingdom, diligently bracing for the next significant pandemic by developing vaccines in advance of looming hazards. You may not need a fourth Covid vaccine now but a flu shot Public health experts suggest that a fourth dose of the Covid vaccine is unnecessary for now. With only 220 million people taking the third dose, a fourth dose may help build resistance, but health experts don't see the need for it as Covid cases in India have drastically decreased. Instead, considering the high number of flu cases in India's cities, vaccinating against flu may be a better To Page 1](#1) of India (SII), world's largest vaccine maker by volumes on Wednesday said its vaccine to protect against the five predominant causes of meningococcal meningitis in Africa has been prequalified by the World Health Organisation (WHO), making the vaccine eligible to be procured by United Nations agencies and Gavi, the Vaccine Alliance. mRNA booster vaccine Gemcovac-OM for Omicron launched at Rs 2,292/dose. Who can take and precautionsGemcovac-OM, the booster vaccine for Omicron from Emcure's subsidiary Gennova, had recently received the nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA). Individuals above 18 years and who have received either Covaxin or Covishield as primary vaccination can take it as a booster for active immunization for the prevention of COVID-19. Sops on cards to make Vaccine Vial MonitorsThe Niti Aayog is spearheading the initiative and is holding discussions with multiple stakeholders to understand the potential and challenges that the country faces in the manufacturing of VVMs. One-shot chikungunya vaccine found safe, effective in first phase 3 trial: Lancet study\"This could be the first chikungunya vaccine available for people living in endemic regions, as well as for travellers to endemic areas or areas at risk for an upcoming outbreak,\" said study lead author, Martina Schneider, Clinical Strategy Manager at Valneva. GSK rolls out its Shingles vaccine in IndiaThe adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilitating pain and rashes caused by the reactivation of the varicella zoster virus (VZV). VZV is the same virus that causes chickenpox. India is one of the countries with highest vaccine confidence: UNICEF reportUNICEF's global flagship report \"The State of the World's Children 2023: For Every Child, Vaccination\" emphasizes the significance of childhood immunisation. India is recognized as one of the countries with the highest vaccine confidence in the world, per Cynthia McCaffrey, UNICEF India Representative. Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccineThe R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months - the age group at the highest risk of death from malaria. It marks the first regulatory clearance for the R21/Matrix-M malaria vaccine for use in any country. Moderna to keep testing flu shot as it fails to meet 'early success' criteriaData from the second trial comes two months after its flu vaccine generated a strong immune response against influenza A strains, but was inferior to an approved vaccine when compared to the less-prevalent influenza B strain in the first late-stage study. Moderna also forecast sales from its respiratory vaccines to be between $8 billion and $15 billion in 2027. It is testing vaccines against respiratory syncytial virus (RSV), influenza and a next-generation COVID-19 shot in late-stage studies. Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer. Vaccination for infants: Here are all do's and don'ts you need to knowThe immunisation procedure can be difficult since newborns can be easily scared, and new parents may be concerned about how the process will proceed or about potential side effects. As new parents, it is natural to feel anxious when your baby exhibits unusual symptoms, but it is vital to seek medical care to soothe and comfort your baby over anything else. China okays its first mRNA vaccine, from drugmaker CSPCChina, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vaccines using messenger RNA (mRNA) technology since early 2020. The long-awaited approval comes as infections have fallen sharply across China since it suddenly dropped its strict \"zero-COVID\" curbs in December, making the sales outlook for the newly approved vaccine moderate. India isolates BF.7 variant, will use it to test efficacy of current vaccines\"Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,\" a TOI source has said. While the variant is not a new discovery - four cases of the BF.7 have been reported in India since July - the isolation and efficacy testing are a step ahead. Sudden COVID-19 outbreaks depict lack of efficacy of Chinese vaccines: ReportIn 2021, Indonesia and Brazil reduced the efficacy to 65 per cent and 50.4 per cent. Both nations raised concerns over the major side effects of COVID vaccine. After the resurgence of COVID-19 cases and deaths, Thailand and Singapore stopped the use of Chinese vaccines and began using vaccines made by AstraZeneca and Pfizer, according to Tibet Press. NTAGI may soon review efficacy data of India's first intranasal Covid vaccineThe date of the meeting is yet to be fixed. India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its Covid-19 intranasal vaccine. The company also received approval to evaluate the intranasal vaccine, BBV 154, as a booster dose on those who have already received both doses of Covaxin. Covid vaccine after infection give higher protection against illness, show 2 Lancet studiesAccording to the first study, conducted in Brazil, researchers found four vaccines provide additional protection against symptomatic reinfection and severe outcomes such as hospitalisation and death in people who have already had a SARS-CoV-2 infection. Covid booster efficacy wanes significantly by fourth month: US studyThe new study was based on more than 241,204 visits to the emergency department or an urgent care clinic, and 93,408 hospitalizations, which are more serious, among adults with Covid-19-like illness during August 26, 2021-January 22, 2022. Leverage the vaccine rollout to mine dataIndia needs to leverage its massive vaccine rollout to use the data it throws up to develop newer and better options. It needs to be forthcoming in publishing the data and analysis. Results on vaccine efficacy against new variant likely next weekIndia's Covid-19 advisory group is hopeful that by next week NIV would be able to culture the virus and may know how the existing vaccines are working, the same people said. Omicron spreads faster and weakens jabs: WHOThe WHO said Omicron had spread to 63 countries as of December 9. Faster transmission was noted in South Africa, where Delta is less prevalent, and in Britain, where Delta is the dominant strain. Covid vaccine boosters not \"appropriate\" at this stage: Lancet studyAccording to the study, even if some gain can ultimately be obtained from booster doses, it will not outweigh the benefits of providing initial protection to those who are still unvaccinated. HUL ties up with Centre for study on vaccine efficacyHindustan Unilever Ltd (HUL) has partnered the Indian government for an academic-based research study which will help understand the factors impacting Covid-19 vulnerability and vaccine efficacy in the country. Sputnik V records 97.8% efficacy against COVID-19 in UAE, fully effective against severe casesIn a statement, the RDIF said that UAE's Ministry of Health confirmed the safety and high efficacy during the vaccination campaign. \"Efficacy among more than 81,000 subjects who had received both components of Sputnik V was 97.8 per cent. Analysis is based on the data collected by June 8, 2021,\" said the RDIF.Load More BACK TO TOP "}